Skip to content
ClinCalc Pro
Menu
Potassium Binder

Sodium Zirconium Cyclosilicate

Brand names: Lokelma

Sodium zirconium cyclosilicate is a non-absorbed potassium-binding agent used to treat hyperkalaemia in adults.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is an insoluble inorganic cation-exchanger that selectively traps potassium ions in exchange for hydrogen and sodium throughout the gastrointestinal tract, increasing faecal potassium excretion.

Prescribing in practice

  • Not for emergency treatment of life-threatening hyperkalaemia because its onset is too slow; use established acute measures first.
  • It can bind co-administered oral drugs, so separate the timing of other medicines that depend on gastric pH or could be affected.
  • It contributes a sodium load, which warrants caution in patients prone to fluid overload such as those with heart failure.

Monitoring

Monitor serum potassium during treatment and adjust therapy to maintain a normal level, watching also for oedema.

Counselling the patient

  • Take as a suspension in water as directed and report swelling, breathlessness or muscle weakness.
  • Space other oral medicines apart from this product as advised by your team.

Evidence & guidelines

MHRA and SPC guidance support its use for chronic hyperkalaemia management rather than acute correction.

Reference: HARMONIZE Trial (Kosiborod et al, JAMA 2014); NICE TA599; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.